Homo sapiens Protein: BCKDHB | |||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Summary | |||||||||||||||||||
InnateDB Protein | IDBP-93566.6 | ||||||||||||||||||
Last Modified | 2014-10-13 [Report errors or provide feedback] | ||||||||||||||||||
Gene Symbol | BCKDHB | ||||||||||||||||||
Protein Name | branched chain keto acid dehydrogenase E1, beta polypeptide | ||||||||||||||||||
Synonyms | dJ279A18.1; E1B; | ||||||||||||||||||
Species | Homo sapiens | ||||||||||||||||||
Ensembl Protein | ENSP00000348880 | ||||||||||||||||||
InnateDB Gene | IDBG-93562 (BCKDHB) | ||||||||||||||||||
Protein Structure |
![]() |
||||||||||||||||||
UniProt Annotation | |||||||||||||||||||
Function | The branched-chain alpha-keto dehydrogenase complex catalyzes the overall conversion of alpha-keto acids to acyl-CoA and CO(2). It contains multiple copies of three enzymatic components: branched-chain alpha-keto acid decarboxylase (E1), lipoamide acyltransferase (E2) and lipoamide dehydrogenase (E3). | ||||||||||||||||||
Subcellular Localization | Mitochondrion matrix. | ||||||||||||||||||
Disease Associations | Maple syrup urine disease 1B (MSUD1B) [MIM:248600]: A metabolic disorder due to an enzyme defect in the catabolic pathway of the branched-chain amino acids leucine, isoleucine, and valine. Accumulation of these 3 amino acids and their corresponding keto acids leads to encephalopathy and progressive neurodegeneration. Clinical features include mental and physical retardation, feeding problems, and a maple syrup odor to the urine. The keto acids of the branched-chain amino acids are present in the urine. If untreated, maple syrup urine disease can lead to seizures, coma, and death. The disease is often classified by its pattern of signs and symptoms. The most common and severe form of the disease is the classic type, which becomes apparent soon after birth. Variant forms of the disorder become apparent later in infancy or childhood and are typically milder, but they still involve developmental delay and other medical problems if not treated. {ECO:0000269PubMed:11509994, ECO:0000269PubMed:22326532, ECO:0000269PubMed:8161368}. Note=The disease is caused by mutations affecting the gene represented in this entry. | ||||||||||||||||||
Tissue Specificity | |||||||||||||||||||
Comments | |||||||||||||||||||
Interactions | |||||||||||||||||||
Number of Interactions |
This gene and/or its encoded proteins are associated with 5 experimentally validated interaction(s) in this database.
|
||||||||||||||||||
Gene Ontology | |||||||||||||||||||
Molecular Function |
|
||||||||||||||||||
Biological Process |
|
||||||||||||||||||
Cellular Component |
|
||||||||||||||||||
Protein Structure and Domains | |||||||||||||||||||
PDB ID | |||||||||||||||||||
InterPro |
IPR005475
Transketolase-like, pyrimidine-binding domain IPR005476 Transketolase, C-terminal IPR009014 Transketolase, C-terminal/Pyruvate-ferredoxin oxidoreductase, domain II IPR029061 Thiamin diphosphate-binding fold |
||||||||||||||||||
PFAM |
PF02779
PF02780 |
||||||||||||||||||
PRINTS | |||||||||||||||||||
PIRSF | |||||||||||||||||||
SMART |
SM00861
|
||||||||||||||||||
TIGRFAMs | |||||||||||||||||||
Post-translational Modifications | |||||||||||||||||||
Modification | |||||||||||||||||||
Cross-References | |||||||||||||||||||
SwissProt | P21953 | ||||||||||||||||||
PhosphoSite | PhosphoSite-P21953 | ||||||||||||||||||
TrEMBL | Q6LCK9 | ||||||||||||||||||
UniProt Splice Variant | |||||||||||||||||||
Entrez Gene | 594 | ||||||||||||||||||
UniGene | Hs.654441 | ||||||||||||||||||
RefSeq | NP_000047 | ||||||||||||||||||
HUGO | HGNC:987 | ||||||||||||||||||
OMIM | 248611 | ||||||||||||||||||
CCDS | CCDS4994 | ||||||||||||||||||
HPRD | 02011 | ||||||||||||||||||
IMGT | |||||||||||||||||||
EMBL | AK289977 AK316545 AL049696 AL391595 BC040139 BT020063 CH471051 D90391 M55575 U50708 U51015 X52446 | ||||||||||||||||||
GenPept | AAA51812 AAB09779 AAB16763 AAH40139 AAV38866 BAA14389 BAF82666 BAH14916 CAA36685 CAC36881 CAI15049 EAW48696 EAW48697 | ||||||||||||||||||